Literature DB >> 2539244

Bombesin stimulates growth of human prostatic cancer cells in vitro.

M Bologna1, C Festuccia, P Muzi, L Biordi, M Ciomei.   

Abstract

Cell proliferation of the human prostatic carcinoma cell line PC3 and of the epithelial cell strain PMU 23 derived from a primary culture of a stage III prostatic carcinoma was enhanced dose dependently by adding 0.1 nM to 10.0 nM bombesin (BMBS) to the culture medium. The growth stimulation was specifically inhibited by antibodies versus Gastrin Releasing Peptide (GRP) crossreacting with BMBS. Presence of BMBS-positive neuroendocrine cells in human prostate and measurable amounts of BMBS-like peptides in prostatic fluid were reported previously. In a binding assay using 125I-GRP, it was possible to demonstrate the presence of saturable specific receptors on PC3 cells, numerically comparable with those measured on small cell lung cancer cell lines. By immunofluorescence, however, no BMBS immunoreactivity on PC3 cells could be demonstrated. These observations suggest that BMBS plays a role in prostatic epithelium growth and that prostatic carcinoma may have an autocrine or paracrine proliferation stimulus within the gland microenvironment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539244     DOI: 10.1002/1097-0142(19900501)63:9<1714::aid-cncr2820630912>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

Authors:  E M Garabedian; P A Humphrey; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Selective reconstitution of gastrin-releasing peptide receptor with G alpha q.

Authors:  M R Hellmich; J F Battey; J K Northup
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.

Authors:  L F Lee; J Guan; Y Qiu; H J Kung
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.

Authors:  G Schwartsmann; L P DiLeone; M Horowitz; D Schunemann; A Cancella; A S Pereira; M Richter; F Souza; A Brondani da Rocha; F H Souza; P Pohlmann; G De Nucci
Journal:  Invest New Drugs       Date:  2006-09       Impact factor: 3.850

5.  Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.

Authors:  Pei-Wen Chen; Glenn S Kroog
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

Review 6.  Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.

Authors:  Lucia Baratto; Hossein Jadvar; Andrei Iagaru
Journal:  Mol Imaging Biol       Date:  2018-08       Impact factor: 3.488

Review 7.  Neuroendocrine peptides in the prostate.

Authors:  P J Gkonos; A Krongrad; B A Roos
Journal:  Urol Res       Date:  1995

8.  Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer.

Authors:  Constantinos Constantinides; Andreas C Lazaris; Konstantinos N Haritopoulos; Dimitrios Pantazopoulos; Michalis Chrisofos; Aris Giannopoulos
Journal:  World J Urol       Date:  2003-07-05       Impact factor: 4.226

9.  Molecular cloning and characterization of receptors for the mammalian bombesin-like peptides.

Authors:  E Giladi; S R Nagalla; E R Spindel
Journal:  J Mol Neurosci       Date:  1993       Impact factor: 3.444

10.  Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.

Authors:  C Festuccia; V Dolo; F Guerra; S Violini; P Muzi; A Pavan; M Bologna
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.